Anti-Inflammatory Actions of a Micronized, Purified Flavonoid Fraction in Ischemia/Reperfusion

  • Ronald J. KorthuisEmail author
  • Dean C. Gute
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 505)


It is now recognized that reperfusion after a prolonged period of reduced or absent blood flow, although necessary to salvage ischemic tissue, initiates a complex series of deleterious reactions which ultimately induce the same effects as ischemia per se, i.e., cell injury and necrosis. Work conducted over the past 15 years has uncovered the fact that postischemic leukocyte infiltration plays a major role in the reperfusion component of ischemia/reperfusion (I/R) injury. This discovery has led to a concerted research effort directed at identifying interventions that prevent post-ischemic leukocyte adhesion and emigration. Recent work indicates that flavonoids are particularly effective anti-inflammatory agents in the setting of I/R. While the mechanisms underlying the powerful protective effects of these compounds is uncertain, a growing body of evidence indicates that flavonoids are potent anti-oxidants that also act to inhibit the activity of key regulatory enzymes involved in the activation of pro-inflammatory signaling cascades. In addition, it appears that these compounds prevent the expression of specific adhesion molecules involved in leukocyte recruitment, observations which provide the molecular basis for the anti-adhesive properties of these compounds.


Leukocyte Adhesion Leukocyte Recruitment Microvascular Dysfunction Leukocyte Rolling Postcapillary Venule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bouskela, E., Cyrino, F. Z. G. A., and Lerond, L. 1999, Leukocyte adhesion after oxidant challenge in the hamster cheek pouch microcirculation, J. Vasc. Res. 36 (suppl. 1): 11–14.CrossRefGoogle Scholar
  2. Bouskela, E., Donyo, K. A., and Verbeuren, T. J., 1995, Effects of Daflon 500 mg on increased microvascular permeability in normal hamsters, Mt. J. Microcirc. 14 (Suppl. 1): 22–26.CrossRefGoogle Scholar
  3. Coleridge-Smith, P. D., 2000, M icronized purified flavonoid fraction and the treatment of chronic venous insufficiency: Microcirculatory mechanisms, Microcirculation 7: S35–S40.CrossRefGoogle Scholar
  4. Dahlgren, M. D., Peterson, M. A., Engler, R. L., and Schmid-Schonbein, G. W., 1984, Leukocyte rheology in cardiac ischemia, Kroc. Found. Ser. 16: 271–283.Google Scholar
  5. Engler, R. L., Schmid-Schonbein, G. W., and Pavelec, R. S., 1983, Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog, Am. J. Pathol. 111: 98–111.Google Scholar
  6. Freisenecker, B., Tsai, A. G., and lntaglietta, M., 1995, Cellular basis of inflammation, edema, and the activity of Daflon 500 mg, Int. J Microcirc. 15 (Suppl. 1): 17–21.CrossRefGoogle Scholar
  7. Freisnecker, B., Tsai, A. G., Allegra, C., and Intaglietta, M., 1994, Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: In vivo observations in the hamster skin fold, Int. J Microcirc. 14: 50–55.CrossRefGoogle Scholar
  8. Gute, D., and Korthuis, R. J., 1995, Role of leukocyte adherence in reperfusion-induced microvascular dysfunction and tissue injury, In Physiology and Pathophysiology of Leukocyte Adhesion; Granger, D. N., and Schmid-Schonbein, G. W., eds., Oxford University Press, New York, NY. pp. 359–380.Google Scholar
  9. Gute, D.C., Ishida, T., Yarimizu, K., and Korthuis. R. J., 1998, Inflammation in ischemia/reperfusion induced skeletal muscle injury: Role of neutrophil adhesion and ischemic preconditioning, Mol. Cell. Biochem. 179: 169–187.CrossRefGoogle Scholar
  10. Halliwell, B., and Gutteridge, J. M. C., 1989, Free Radicals in Biology and Medicine, Clarendon Press, Oxford.Google Scholar
  11. Jerome, S. N., Akimitsu, T., and Korthuis, R. J. 1994, Leukocyte adhesion, edema and post-ischemic capillary noreflow, Am. J PhysioL 267: H1329–H1336.Google Scholar
  12. Korthuis, R. J., Carden, D. L., and Granger, D. N., 1992, Cellular dysfunction induced by ischemia/reperfusion: role of reactive oxygen metabolites and granulocytes, In Biological Consequences of Oxidative Stress: Implications for Cardiovascular Disease and Carcinogenesis Spatz, L., and Bloom, A. D., eds., Oxford University Press, New York, NY, pp. 50–77.Google Scholar
  13. Korthuis, R. J., and Granger, D. N., 1995, Mechanisms of ischemia/reperfusion injury, Ann. Rev. Physiol. 57:311–332CrossRefGoogle Scholar
  14. Korthuis, R. J., and Gute, D. C., 1997, Post-ischernic leukocyte/endothelial cell interactions and microvascular barrier dysfunction in skeletal muscle: Cellular mechanisms and the effect of Daflon 500 mg, Int. J. Microcirc. 19 (Suppl. 1): 11–17.CrossRefGoogle Scholar
  15. Korthuis, R. J., and Gute, D. C., 1999, Adhesion molecule expression in post-ischemic microvascular dysfunction: Activity of a micronized purified flavonoid fraction, J. Vasc. Res. 36 (suppl. 1): 15–23.CrossRefGoogle Scholar
  16. Lerond, L., 1994, Action of Daflon 500 mg on the principal inflammatory mediators, Phlebology 9(Suppl. 1):34–39..Google Scholar
  17. Manthey, J. A., 2000, Biological properties of flavonoids pertaining to inflammation, Microcirculation 7: S29–S34.CrossRefGoogle Scholar
  18. Nolte, D., Pickelmann, S., Mollman, M., Schutze, E., Kubler, W., Leiderer, R., and Messmer, K., 1999, Effects of the phlebotriopic drug Daflon 500 on postischemic microvascular disturbances in striated skin muscle: an intravital microscopic study in the hamster, J. Lab. Clin. Med. 134: 526–535.CrossRefGoogle Scholar
  19. Panes, J., and Granger, D. N., 1998, Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal disease, Gastroenterology 114: 1066–1090.CrossRefGoogle Scholar
  20. Rubin, B. B., Romaschin, A., Walker, P. M., Gute, D. C., and Korthuis, R. J.. 1996, Mechanisms of post-ischemic skeletal muscle dysfunction: Intervention strategies, J. Appl. Physiol 80: 369–387.Google Scholar
  21. Takase, S., Delano, TA., Lerond, L., Bergan, J. J., and Schmid-Schonbein, G. W., 1999, Inflammation in chronic venous insufficiency: Is the problem insurmountable? J. Vasc. Res. 36 (suppl. I): 3–10.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  1. 1.Louisiana State University Health Sciences Center, School of Medicine in ShreveportDepartment of Molecular and Cellular PhysiologyShreveportUSA

Personalised recommendations